India has followed the U.K. and granted emergency approval for the coronavirus vaccine developed by AstraZeneca Plc and the University of Oxford, the first step in its plan to inoculate citizens in the country that’s home to the world’s second-largest Covid-19 outbreak.
: Sunday, January 3, 2021, 10:54 PM IST
Oxford, Bharat Biotech s vaccines approved for emergency use; PM hails it as âMade in Indiaâ moment
Representational Image
Your eternal wait for the prick of a needle is over â a prick that may add years to your life and, more important, change your outlook towards it.
Redemption lies for the suffering millions in two vaccines that have been cleared by the drugs regulator for restricted emergency use in the country.
While UK-based Oxford Institute s Covishield has been developed by the Pune-based Serum Institute, Hyderabad-based Bharat Biotech s Covaxin is an outcome of collaboration with the Indian Council of Medical Research. To that extent, both vaccines are home-spun.
India has followed the U.K. and granted emergency approval for the coronavirus vaccine developed by AstraZeneca Plc and the University of Oxford, the first step in its plan to inoculate citizens in the country that’s home to the world’s second-largest Covid-19 outbreak.